Page last updated: 2024-09-05

organophosphonates and Infections, Helicobacter

organophosphonates has been researched along with Infections, Helicobacter in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Baszczyňski, O; Eng, WS; Ferrero, RL; Guddat, LW; Hocková, D; Keough, DT; Naesens, L; Panjikar, S; Pohl, R; Rejman, D; Špaček, P; Wun, SJ1
Adachi, E; Fujii, T; Iwamoto, A; Kikuchi, T; Koga, M; Koibuchi, T; Ohno, N; Okame, M; Ota, Y; Oyaizu, N; Sato, H; Takaya, S1
Nightingale, SL1

Other Studies

3 other study(ies) available for organophosphonates and Infections, Helicobacter

ArticleYear
    Journal of medicinal chemistry, 2021, 05-13, Volume: 64, Issue:9

    Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Binding Sites; Crystallography, X-Ray; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Hypoxanthine Phosphoribosyltransferase; Hypoxanthines; Kinetics; Molecular Dynamics Simulation; Organophosphonates; Pentosyltransferases; Prodrugs; Sequence Alignment; Structure-Activity Relationship

2021
Complete regression of early-stage gastric diffuse large B-cell lymphoma in an HIV-1-infected patient following Helicobacter pylori eradication therapy.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2014, Volume: 58, Issue:10

    Topics: Adenine; Amoxicillin; Anti-Bacterial Agents; Antiretroviral Therapy, Highly Active; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; HIV-1; Humans; Lansoprazole; Lymphoma, AIDS-Related; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Organophosphonates; Pyrrolidinones; Raltegravir Potassium; Tenofovir

2014
From the Food and Drug Administration.
    JAMA, 1996, Dec-04, Volume: 276, Issue:21

    Topics: Anti-HIV Agents; Antiviral Agents; Breath Tests; Cidofovir; Cytosine; Helicobacter Infections; Helicobacter pylori; HIV Protease Inhibitors; Humans; Organophosphonates; Organophosphorus Compounds; Prostheses and Implants; Renal Insufficiency; Spinal Fusion; United States; United States Food and Drug Administration

1996